Carys Smith has been at the forefront of developments in legislation that affect advertising standards and regulations which impact FMCG industries at Ayton Global Research since 2012. This knowledge has been put to good effect when working closely with international clients including Walgreen Boots Alliance, Meiyume, Oriflame, PZ Cussons, Acheson & Acheson, S&J International, Guthy Renker, Jalco, The Body Shop and many more.
Carys has designed, overseen and managed studies for over 250 clients and is in a great position to lecture about global trends in FMCG industries, consumer research and claims testing.
Carys has travelled globally to countries within Asia, Europe, the USA and more to provide lectures and discussions on the topic of advertising, testing methodologies, claim substantiation and the regulations and laws which surround this process.
Dr Paul Smith is the Secretary General of Botanic Gardens Conservation International (BGCI). BGCI is the largest plant conservation network in the world, comprising 600 member institutions in 100 countries. Paul joined BGCI as Secretary General in March 2015. Prior to this, Paul was Head of the Royal Botanic Garden, Kew’s Millennium Seed Bank (MSB). During his nine years at the helm there, seeds from >25,000 plant species were conserved in the MSB and, in 2009, the MSB achieved its first significant milestone, securing seed from 10% of the world’s plant species, prioritising rare, threatened and useful plants. Paul trained as a plant ecologist, and is a specialist in the plants and vegetation of southern Africa. He is the author of two field guides to the flora of south-central Africa and the Vegetation Atlas of Madagascar. He is a Trustee of the National Botanic Garden of Wales, and is the recipient of the New England Wildflower Society’s Medal for Services to International Plant Conservation and the David Fairchild Medal for Plant Exploration.
Accomplished Director level manager with over 10 years of management experience in diverse setting. Innovative, data-driven and multi-disciplinary leader, expertise in CMC, Formulation, Drug Delivery and Development Platforms. Extensive knowledge in Immune system, cardiovascular, and cancer. In top industry and academic labs
Have over 27 years’ experience in clinical trials management. Prior to joining V-Wave medical as Director of Clinical Affairs i worked at PolyPid as Senior Clinical Development for 1.5 years and worked for 12 years at Medinol Ltd., where i was responsible for leading the operations of the company’s coronary/peripheral/drug-eluting stenting clinical trials. I have also managed various clinical trials at Bristol Myers Squibb (BMS) and Bayer pharmaceutical companies. I hold RN and medical administration degrees from Tel-Aviv University, and an MBA from Herriot-Watt University, Edinburgh Business School.
Nadeeka is a neuroscientist and digital health outcomes expert with in-depth experience consulting on pre- and post-approval clinical trials. At ERT, Dr. Dias provides scientific and technology guidance to global sponsors on electronic clinical outcome assessments (eCOA) across several therapeutic areas. In addition to leading the ERT Science team in thought leadership strategy, her expertise extends to eCOA regulatory guidance, instrument development and validation, and eCOA product/software design. She has presented numerous abstracts at global conferences and published several articles on the patient perspective in clinical trials. Prior to joining ERT, Dr. Dias conducted clinical research at Harvard Medical School.
A courageous Quality Leader with lots of broad experience and the ability to motivate people at the team and individual level.
An Innovative, “out of the box” thinker with excellent communication skills.
